# New York Blood Center Enterprises – FDA Inspection, Dec 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/54a6d6af-8eaa-48b0-a2dc-40d16ce255d4
Source feed: FDA_Inspections

> FDA inspection 1226373 of New York Blood Center Enterprises, December 22, 2023. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226373
- Company Name: New York Blood Center Enterprises
- Inspection Date: 2023-12-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1313734 - 2026-04-23](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/4dba5893-4e1a-4c8e-bb21-4208e3e34b7a)
- FDA Inspection 1110447 - 2019-11-06
- FDA Inspection 1012914 - 2017-05-04
- FDA Inspection 940732 - 2015-09-04
- FDA Inspection 852575 - 2013-10-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/new-york-blood-center-enterprises/9f2a4f56-c3b2-4ee4-95a2-a77827302570

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
